Navigation Links
Global Peripheral Vascular Devices Market 2010-2014
Date:9/15/2011

NEW YORK, Sept. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Peripheral Vascular Devices Market 2010-2014

http://www.reportlinker.com/p0615915/Global-Peripheral-Vascular-Devices-Market-2010-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

Technavio's analysts forecast the Global Peripheral Vascular Devices market to grow at a CAGR of 7 percent over the period 2010–2014. One of the key factors contributing to this market growth is the increase in patent grants and Food and Drug Administration (FDA) approvals. The Global Peripheral Vascular Devices market has also been witnessing an increase in carotid stent usage. However, infections from cardiac pacemakers could pose a challenge to the growth of this market.

Key vendors dominating this market include Abbott Laboratories, Cordis Corp., Boston Scientific Corp., C.R. Bard Inc., and Medtronic Inc.

Technavio's Global Peripheral Vascular Devices Market 2010–2014 report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report, which covers the Americas as well as the EMEA and the APAC regions, covers the current market landscape and its growth prospects. The report also includes a discussion on the key vendors operating in this market.

Key questions answered in this report:

What will the market size be in 2014 and at what rate will it grow?

What key trends is this market subject to?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the opportunities and threats faced by each of these key vendors?

What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Vendor Landscape

06. Buying Criteria

07. Market Growth Drivers

08. Drivers and their Impact

09. Market Challenges

10. Market Trends

11. Key Vendor Analysis

11.1 Abbott Laboratories

11.2 Cordis Corp.

11.3 Boston Scientific Corp.

11.4 C.R. Bard Inc.

11.5 Medtronic Inc.

12. Other Reports in this Series

List of Exhibits

Exhibit 1: Global Peripheral Vascular Devices Market 2010–2014 (US$ billion)

Exhibit 2: Global Peripheral Vascular Devices Market by Geographical Segmentation 2010

Exhibit 3: Market Share of Key Global Peripheral Vascular Devices Market Vendors—2010

To order this report:

Cardiovascular Devices Industry: Global Peripheral Vascular Devices Market 2010-2014

Cardiovascular Devices Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Digital Radiography Market 2010-2014
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
3. Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference
4. Mettler-Toledo International Inc. Announces Webcast of Presentation at UBS Global Life Sciences Conference
5. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
6. Chiasma to Present at the UBS Global Life Sciences Conference
7. CIVCO Integrates Global Sales Structure, Names New Sales Leadership Roles
8. Medtech and MedicAlert Create Global Connection for Rugby World Cup 2011
9. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
10. Gates Foundation Names Dr. Trevor Mundel to Lead Global Health Program
11. Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Oesophageal ... their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies - ... Cancer market. The research answers the following questions: ... Oesophageal Cancer and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... VALLEY COTTAGE, New York , February 23, 2017 ... to health implications arising from increasing caseload for varicose ... cases recorded across the globe are prompting the adoption ... A latest study on global endovenous laser therapy ... growing attention towards aftereffects of lifestyle choices and consequences ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over Heels’ ... February 12th. Ms. Esparza qualified into this prestigious status after winning the ... Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to the La Gorce Country Club in Miami Beach to host its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... and uncertainty in clinical trials, today announced that Premier Research, a leading clinical ... solution. , Clinical trials are becoming increasingly complex, due in part to an ...
Breaking Medicine News(10 mins):